Dr. Janeway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana Farber Cancer Institute
44 Binney Street
Boston, MA 02115Phone+1 617-632-4994
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2004
- Harvard Medical SchoolClass of 2000
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 2003 - 2026
- RI State Medical License 2022 - 2026
- CT State Medical License 2022 - 2025
- NH State Medical License 2024 - 2024
- VT State Medical License 2022 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- iCAT for Recurrent/Refractory/HR Solid Tumors Start of enrollment: 2012 Aug 01
- The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study Start of enrollment: 2015 Oct 01
- Olaparib With Ceralasertib in Recurrent Osteosarcoma Start of enrollment: 2020 Nov 24
Publications & Presentations
PubMed
- 1 citationsOvercoming Systemic Barriers to Make Patient-Partnered Research a Reality.Vinayak Venkataraman, Bailey A Martin-Giacalone, Bettina F Drake, Liz Salmi, Elizabeth B Claus
Journal of Clinical Oncology. 2024-12-01 - Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, Quentin Campbell-Hewson, Filemon S Dela Cruz
JAMA Oncology. 2024-10-17 - Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report.Lenka Ilcisin, Ruxu Han, Mark Krailo, David S Shulman, Brent R Weil
Journal of the National Cancer Institute. 2024-10-01
Journal Articles
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
- Integrated Genetic and Pharmacologic Interrogation of Rare CancersAndrew L Hong, Katherine A Janeway, Brian D Crompton, Kimberly Stegmaier, Levi A Garraway, Alanna J Church, Stuart L Schreiber, William C Hahn, Nature
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Refining the Genomic Landscape of Pediatric Cancers2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Chemotherapy and radiation therapy in the management of osteosarcomaJaneway KA, Goorin AM, Maki R
http://www.uptodate.com/contents/chemotherapy-and-radiation-therapy-in-the-management-of-osteosarcom
UpToDate, Wolters Kluwer Health - 2012-12-06
Press Mentions
- Genomic ‘Fingerprinting’ Yields Better Treatments for Pediatric Solid CancersJune 24th, 2022
- Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical CareJune 23rd, 2022
- A Discussion with Cancer Discovery’s Editors-in-ChiefAugust 5th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: